ExploreInterventionpreterm severity-stratified metabolic screening
Intervention

preterm severity-stratified metabolic screening

Also known as: Preterm severity-stratified metabolic screening (early vs late preterm, spontaneous vs medically indicated)
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
outcomes
populations
studys

Findings (27)

None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86

Papers (1)